Clinical Trial Update: Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing a targeted therapy with chemotherapy in patients with refractory differentiated thyroid carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Refractory Differentiated Thyroid Gland Carcinoma | Phase 3 | Status: RECRUITING